Small Cell Lung Cancer remains among the most devastating malignancies confronting contemporary clinical practice, distinguished by its rapid progression and resistance to long-term therapeutic control. While patients initially exhibit encouraging responses to standard chemotherapy and radiation protocols, disease recurrence occurs almost inevitably, producing survival rates markedly...